S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in
NASDAQ:APHA

Aphria Stock Forecast, Price & News

$12.92
+0.24 (+1.89 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$12.08
Now: $12.92
$13.03
50-Day Range
$6.82
MA: $8.32
$13.61
52-Week Range
$1.95
Now: $12.92
$14.01
Volume10.96 million shs
Average Volume21.62 million shs
Market Capitalization$3.86 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.67
Aphria, Inc. engages in the production and supply of medical cannabis. It operates through the following segments: Cannabis Operations, Distribution Operations, and Business Under Development. The Cannabis Operations segment produces, distributes, and sells both medical and adult-use cannabis. The Distribution Operations segment are carried out through its wholly owned subsidiaries ABP, FL Group, and CC Pharma. The Distribution Under Development segment includes operations in which the firm has not received final licensing or has not commenced commercial sales from operations. The company was founded by Cole Cacciavillani and John Cervini in 2013 and is headquartered in Leamington, Canada.

MarketRank

Overall MarketRank

1.73 out of 5 stars

Medical Sector

179th out of 1,922 stocks

Medicinals & Botanicals Industry

2nd out of 33 stocks

Analyst Opinion: 4.3Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:APHA
CUSIPN/A
CIKN/A
Phone(844) 427-4742
Employees1,200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$405.96 million
Cash Flow$0.08 per share
Book Value$4.80 per share

Profitability

Net Income$-63,210,000.00

Miscellaneous

Market Cap$3.86 billion
Next Earnings Date4/13/2021 (Estimated)
OptionableOptionable
$12.92
+0.24 (+1.89 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aphria (NASDAQ:APHA) Frequently Asked Questions

How has Aphria's stock been impacted by COVID-19?

Aphria's stock was trading at $2.70 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APHA shares have increased by 378.5% and is now trading at $12.92.
View which stocks have been most impacted by COVID-19
.

Is Aphria a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria in the last year. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Aphria stock.
View analyst ratings for Aphria
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Aphria?

Wall Street analysts have given Aphria a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Aphria wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Aphria's next earnings date?

Aphria is scheduled to release its next quarterly earnings announcement on Tuesday, April 13th 2021.
View our earnings forecast for Aphria
.

How were Aphria's earnings last quarter?

Aphria Inc. (NASDAQ:APHA) posted its quarterly earnings data on Wednesday, January, 13th. The company reported ($0.42) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.39. The company earned $160.50 million during the quarter, compared to analysts' expectations of $153.75 million. Aphria had a negative net margin of 36.10% and a negative trailing twelve-month return on equity of 2.30%. The company's revenue for the quarter was up 33.1% compared to the same quarter last year. During the same period in the prior year, the firm earned ($0.03) EPS.
View Aphria's earnings history
.

What price target have analysts set for APHA?

9 equities research analysts have issued 12 month price targets for Aphria's shares. Their forecasts range from $7.00 to $26.00. On average, they expect Aphria's stock price to reach $17.00 in the next twelve months. This suggests a possible upside of 31.6% from the stock's current price.
View analysts' price targets for Aphria
or view Wall Street analyst' top-rated stocks.

Who are some of Aphria's key competitors?

What other stocks do shareholders of Aphria own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria investors own include AbbVie (ABBV), Alibaba Group (BABA), (CGC), Mastercard (MA), Square (SQ), Aurora Cannabis (ACB), Abbott Laboratories (ABT), Alteryx (AYX), Big Lots (BIG) and BlackRock (BLK).

Who are Aphria's key executives?

Aphria's management team includes the following people:
  • Irwin David Simon, Chairman & Chief Executive Officer
  • James R. Meiers, Chief Operating Officer-Aphria Leamington
  • Carl A. Merton, Chief Financial Officer
  • Denise Menikheim Faltischek, Chief Strategy Officer
  • Bernard Yeung, Senior Vice President-Sales & Marketing

What is Aphria's stock symbol?

Aphria trades on the NASDAQ under the ticker symbol "APHA."

Who are Aphria's major shareholders?

Aphria's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Kestra Advisory Services LLC (0.02%), TL Private Wealth (0.01%), Traynor Capital Management Inc. (0.00%), Grassi Investment Management (0.00%) and Johnson Midwest Financial LLC (0.00%).

Which major investors are selling Aphria stock?

APHA stock was sold by a variety of institutional investors in the last quarter, including TL Private Wealth.

Which major investors are buying Aphria stock?

APHA stock was bought by a variety of institutional investors in the last quarter, including Kestra Advisory Services LLC, Traynor Capital Management Inc., Grassi Investment Management, and Johnson Midwest Financial LLC.

How do I buy shares of Aphria?

Shares of APHA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aphria's stock price today?

One share of APHA stock can currently be purchased for approximately $12.92.

How big of a company is Aphria?

Aphria has a market capitalization of $3.86 billion and generates $405.96 million in revenue each year. The company earns $-63,210,000.00 in net income (profit) each year or ($0.06) on an earnings per share basis. Aphria employs 1,200 workers across the globe.

What is Aphria's official website?

The official website for Aphria is aphriainc.com.

How can I contact Aphria?

Aphria's mailing address is 98 TALBOT STREET W., LEAMINGTON A6, N8H 1M8. The company can be reached via phone at (844) 427-4742 or via email at [email protected]

This page was last updated on 1/23/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.